Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study

Introduction: The temporomandibular disorders (TMDs) include a heterogeneous group of clinical conditions affecting the stomatognathic system and its related structures. It is characterized by pain specific to the maxillofacial region, and these disorders are the main cause of chronic facial pain an...

Full description

Bibliographic Details
Main Authors: Amit Gupta, Anju Aggarwal, Anurag Aggarwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Pain
Subjects:
Online Access:http://www.indianjpain.org/article.asp?issn=0970-5333;year=2016;volume=30;issue=3;spage=166;epage=170;aulast=Gupta
_version_ 1818290249922510848
author Amit Gupta
Anju Aggarwal
Anurag Aggarwal
author_facet Amit Gupta
Anju Aggarwal
Anurag Aggarwal
author_sort Amit Gupta
collection DOAJ
description Introduction: The temporomandibular disorders (TMDs) include a heterogeneous group of clinical conditions affecting the stomatognathic system and its related structures. It is characterized by pain specific to the maxillofacial region, and these disorders are the main cause of chronic facial pain and disability. Management of TMDs is challenging due to the unknown etiology and complex anatomy of the temporomandibular joint region. Aim and Objectives: To evaluate the effect of botulinum toxin type-A (BTX-A) on pain and day to day functional and social activities of myofascial pain with or without TMDs, and to compare the effectiveness of BTX-A with a placebo group with the aid of EMG and a Behavioural Questionnaire. Materials and Methods: The study was done on 24 patients randomly divided into two groups and each group contains 12 participants. The study group showed a statistically significant decrease in the muscle activity after 14 days, and the patients responded that there was a significant reduction in the pain and improvement in their day-to-day functional as well as social activities after BTX-A treatment with 8 months follow-up. Conclusion: BTX-A has been proven to have positive desired effects on patients with TMDs.
first_indexed 2024-12-13T02:25:11Z
format Article
id doaj.art-5daaa1cb3807424b96b0e07b0aa0a704
institution Directory Open Access Journal
issn 0970-5333
language English
last_indexed 2024-12-13T02:25:11Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pain
spelling doaj.art-5daaa1cb3807424b96b0e07b0aa0a7042022-12-22T00:02:40ZengWolters Kluwer Medknow PublicationsIndian Journal of Pain0970-53332016-01-0130316617010.4103/0970-5333.198013Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled studyAmit GuptaAnju AggarwalAnurag AggarwalIntroduction: The temporomandibular disorders (TMDs) include a heterogeneous group of clinical conditions affecting the stomatognathic system and its related structures. It is characterized by pain specific to the maxillofacial region, and these disorders are the main cause of chronic facial pain and disability. Management of TMDs is challenging due to the unknown etiology and complex anatomy of the temporomandibular joint region. Aim and Objectives: To evaluate the effect of botulinum toxin type-A (BTX-A) on pain and day to day functional and social activities of myofascial pain with or without TMDs, and to compare the effectiveness of BTX-A with a placebo group with the aid of EMG and a Behavioural Questionnaire. Materials and Methods: The study was done on 24 patients randomly divided into two groups and each group contains 12 participants. The study group showed a statistically significant decrease in the muscle activity after 14 days, and the patients responded that there was a significant reduction in the pain and improvement in their day-to-day functional as well as social activities after BTX-A treatment with 8 months follow-up. Conclusion: BTX-A has been proven to have positive desired effects on patients with TMDs.http://www.indianjpain.org/article.asp?issn=0970-5333;year=2016;volume=30;issue=3;spage=166;epage=170;aulast=GuptaBotulinum toxin type-Amyofascial paintemporomandibular disorders
spellingShingle Amit Gupta
Anju Aggarwal
Anurag Aggarwal
Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
Indian Journal of Pain
Botulinum toxin type-A
myofascial pain
temporomandibular disorders
title Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
title_full Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
title_fullStr Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
title_full_unstemmed Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
title_short Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
title_sort effect of botulinum toxin a in myofascial pain in temporomandibular disorders a randomized double blinded placebo controlled study
topic Botulinum toxin type-A
myofascial pain
temporomandibular disorders
url http://www.indianjpain.org/article.asp?issn=0970-5333;year=2016;volume=30;issue=3;spage=166;epage=170;aulast=Gupta
work_keys_str_mv AT amitgupta effectofbotulinumtoxinainmyofascialpainintemporomandibulardisordersarandomizeddoubleblindedplacebocontrolledstudy
AT anjuaggarwal effectofbotulinumtoxinainmyofascialpainintemporomandibulardisordersarandomizeddoubleblindedplacebocontrolledstudy
AT anuragaggarwal effectofbotulinumtoxinainmyofascialpainintemporomandibulardisordersarandomizeddoubleblindedplacebocontrolledstudy